United States Diagnostics Market to Witness Significant Growth until 2025
Increasing geriatric population to drive the growth of United
States diagnostics market
According
to TechSci Research report, “United
States Diagnostics Market By Product Type (Reagents, Instruments, Software
& Services), By Type of Test (Lipid Panel, Metabolic Panel, Infectious
Disease Testing, Others), By Technique (Immunodiagnostics, Molecular
Diagnostics, Tissue Diagnostics, Clinical Techniques, Others), By Usability
(Reusable v/s Disposable), By Application (Infectious Diseases, Cancer, Cardiac
Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal
Diseases, Others), By End User (Hospitals, Public labs, Diagnostic Centers,
Point-of-Care Testing Centers, Private or Commercial Laboratories, Others), By Region, Forecast & Opportunities, 2025”, the United States diagnostics market is expected to grow
at an impressive rate during the forecast period on account of the changing
lifestyle and dietary habits of the people. This has led to an increase in the
prevalence of diseases such as cancer, diabetes, asthma, cardiovascular
diseases, renal disorders, hypertension, among others. Stats show that every
year more than 1.5 million people die because of these diseases in the country.
This has increased the demand for diagnostics in the country so that such
diseases could be detected early, and the patients can get appropriate
treatment. Additionally, growing number of accredited laboratories, point of
care testing centers, hospitals, among others is expected to further fuel the
market growth. Furthermore, increasing penetration of health insurance
providers is expected to create lucrative opportunities for the market growth.
However, dearth of skilled professionals in the laboratories might hamper the
market growth through 2025. Additionally, need for high complexity testing
centers might further restrict the market growth over the next few years. Also,
high cost of tests and budget constraints might further hinder the market
growth during the forecast period.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on " United
States Diagnostics Market"
https://www.techsciresearch.com/report/united-states-diagnostics-market/4797.html
The United States diagnostics market is segmented based on product type,
type of test, technique, usability, application, end user, company and region.
Based on product type, the market can be categorized into reagents, instruments
and software & services. Among these, the reagents segment is expected to
dominate the market owing to the increasing number of diagnostic tests being
performed which have increased the demand for reagents. On the other hand, the
instrument segment is expected to register significant growth in the market
owing to the increasing demand for advanced medical instruments and equipment,
which deliver accurate and reliable diagnostic test results. Based on
technology, the market can be categorized into immunodiagnostics, molecular
diagnostics, tissue diagnostics, clinical techniques and others. Here, the molecular
diagnostics market is expected to dominate the market owing to the increasing
application of molecular diagnostic techniques in point of care testing and
pharmacogenetics. Additionally, increasing number of blood tests being
performed on account of the growing prevalence of diseases is further driving
the segmental growth. Based on application, the market can be grouped into
infectious diseases, cancer, cardiac diseases, immune system disorders,
nephrological diseases, gastrointestinal diseases and others. Among these, the infectious
diseases segment is expected to register the highest growth in the market owing
to the growing prevalence of infectious diseases. Furthermore, the outbreak and
spread of pandemic COVID-19 which is also an infectious disease is further expected
to drive the segmental growth through 2025. Based on end user, the market can
be fragmented into hospitals & clinics, diagnostic centers, point-of-care
testing centers, private or commercial laboratories and others. The hospitals
segment is expected to dominate the market owing to the increasing volumes of
tests being conducted in hospitals.
Abbott Laboratories, Inc., Danaher Corporation, Thermo Fisher
Scientific, Inc., Johnson & Johnson, Ortho-Clinical Diagnostics, Becton,
Dickinson, and Company, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd, Siemens
Healthcare, Perkin Helmer and others are some of the leading players operating
in United States diagnostics market. The companies operating in the market are
using organic strategies such as product launches, mergers and collaborations
to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4797
Customers can also
request for 10% free customization on this report.
“United States diagnostics market is
expected to witness significant growth during the forecast period, on account
of the increasing demand for personalized medicines and companion diagnostics.
Additionally, technological advancements in the health care industry with the
advent of AI, cloud computing, IoT, among others, is further expected to propel
the market growth through 2025. Additionally, presence of major pharmaceutical
& biotechnology giants in the country is further expected to create
lucrative opportunities for the market growth over the next few years.” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“United States Diagnostics Market By Product Type
(Reagents, Instruments, Software & Services), By Type of Test (Lipid Panel,
Metabolic Panel, Infectious Disease Testing, Others), By Technique
(Immunodiagnostics, Molecular Diagnostics, Tissue Diagnostics, Clinical
Techniques, Others), By Usability (Reusable v/s Disposable), By Application
(Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders,
Nephrological Diseases, Gastrointestinal Diseases, Others), By End User (Hospitals, Public labs,
Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial
Laboratories, Others), By
Region, Forecast & Opportunities, 2025”, has evaluated
the future growth potential of United States diagnostics market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in United States diagnostics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]